newsfilter
← Latest News
GlobeNewswire·

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, Ireland, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (NASDAQ:MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to